Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SARS-CoV-2 antigen rapid detection tests: test performance during the COVID-19 pandemic and the impact of COVID-19 vaccination.
Wagenhäuser I, Knies K, Pscheidl T, Eisenmann M, Flemming S, Petri N, McDonogh M, Scherzad A, Zeller D, Gesierich A, Seitz AK, Taurines R, Ernestus RI, Forster J, Weismann D, Weißbrich B, Liese J, Härtel C, Kurzai O, Dölken L, Gabel A, Krone M. Wagenhäuser I, et al. Among authors: kurzai o. EBioMedicine. 2024 Oct 9;109:105394. doi: 10.1016/j.ebiom.2024.105394. Online ahead of print. EBioMedicine. 2024. PMID: 39388783 Free article.
Clinical accuracy of SARS-CoV-2 rapid antigen testing in screening children and adolescents.
Krone M, Wagenhäuser I, Knies K, Hofmann D, Engels G, Taurines R, McDonogh M, Flemming S, Meyer T, Böhm H, Scherzad A, Eisenmann M, Rauschenberger V, Gabel A, Petri N, Reusch J, Forster J, Weißbrich B, Dölken L, Kurzai O, Vogel U, Härtel C, Liese J, Andres O. Krone M, et al. Among authors: kurzai o. J Infect. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2022.12.017. Epub 2022 Dec 21. J Infect. 2023. PMID: 36565725 Free PMC article. No abstract available.
Heterologous and homologous COVID-19 mRNA vaccination schemes for induction of basic immunity show similar immunogenicity regarding long-term spike-specific cellular immunity in healthcare workers.
Wagenhäuser I, Almanzar G, Förg FB, Stein A, Eiter I, Reusch J, Mees J, Herzog A, Vogel U, Frey A, Lâm TT, Schubert-Unkmeir A, Dölken L, Kurzai O, Frantz S, Gabel A, Petri N, Prelog M, Krone M. Wagenhäuser I, et al. Among authors: kurzai o. Vaccine. 2024 Aug 30;42(21):126132. doi: 10.1016/j.vaccine.2024.07.033. Epub 2024 Jul 20. Vaccine. 2024. PMID: 39034219 Free article.
Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster.
Wagenhäuser I, Reusch J, Gabel A, Krone LB, Kurzai O, Petri N, Krone M. Wagenhäuser I, et al. Among authors: kurzai o. Clin Microbiol Infect. 2023 Apr;29(4):554-556. doi: 10.1016/j.cmi.2023.01.008. Epub 2023 Jan 16. Clin Microbiol Infect. 2023. PMID: 36657489 Free PMC article. No abstract available.
Determinants of Influenza A infection rate in post-COVID-19 era.
Wagenhäuser I, Mees J, Reusch J, Lâm TT, Schubert-Unkmeir A, Krone LB, Frey A, Kurzai O, Frantz S, Dölken L, Liese J, Gabel A, Petri N, Krone M. Wagenhäuser I, et al. Among authors: kurzai o. J Infect. 2023 Oct;87(4):361-364. doi: 10.1016/j.jinf.2023.08.003. Epub 2023 Aug 9. J Infect. 2023. PMID: 37567511 Free article. No abstract available.
SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022.
Engels G, Oechsle AL, Schlegtendal A, Maier C, Holzwarth S, Streng A, Lange B, Karch A, Petersmann A, Streeck H, Blaschke-Steinbrecher S, Härtel C, Schroten H, von Kries R, Berner R, Liese J, Brinkmann F, Toepfner N; IMMUNEBRIDGE KIDS study group. Engels G, et al. Infection. 2023 Oct;51(5):1531-1539. doi: 10.1007/s15010-023-02052-5. Epub 2023 Jun 6. Infection. 2023. PMID: 37280412 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 36326900
226 results